HIPAA Compliant ยท GDPR ยท Peer-Reviewed ยท Pat. No. 12,220,237

Bridge the Gap
Between Sessions
with Continuous Monitoring

Behavidence delivers objective, real-time insights into your patients' mental health trajectory, continuously captured between visits, requiring nothing more from them than their phone.

Specifically designed for clinics providing Esketamine, TMS, and SSRI treatment.

The Challenge

You See Patients Every 6 to 8 Weeks.
They Change Every Day.

Psychiatric symptoms evolve rapidly. A patient stabilized on Esketamine, TMS, or SSRIs can shift trajectory, for better or worse, in the space between appointments. Without continuous observation, critical windows slip by unnoticed.

35%

of first-line treatments result in minimal response

50%

of patients experience relapse within one year post-treatment

40%

of relapsed patients disengage before re-engagement attempts succeed

The Outcome Cost

Every missed relapse is both a clinical failure and a lost opportunity to adjust protocols, explore alternatives, or prevent further decline.

By Treatment

Tailored for Your Protocol

Whether you're running an Esketamine clinic, TMS center, or managing SSRI patients, Behavidence gives you the continuous visibility you need.

๐Ÿ’Š Esketamine: Monitor the rapid-treatment window

Esketamine's fast onset is its strength and its vulnerability. Response can deteriorate days after successful induction, but your next infusion assessment is weeks away.

  • Detect emergence of non-response or early relapse within 48 hours of onset
  • 24/7 behavioral tracking to identify slip patterns between infusions
  • Real-time clinician alerts when mood trajectories shift unexpectedly
  • Objective tracking of functional recovery and dissociation markers
~70%

of TRD patients who respond to Esketamine relapse within 6 months without maintenance (PMC10267177)

51%

Reduction in relapse risk when Esketamine is continued alongside an antidepressant (JAMA Psychiatry)

43%

of patients do not achieve stable remission during the induction phase alone (Spravato HCP data)

How It Works

Zero Burden. Full Visibility.

๐Ÿ“ฑ
01

Patient Downloads the App

Your patient installs the Behavidence app. No wearables, no daily questionnaires. It runs passively in the background.

๐Ÿ”„
02

Passive Data Collection

Our validated algorithms capture behavioral biomarkers: sleep, activity, digital behavior patterns, and more. 24/7.

๐Ÿค–
03

AI Analysis

Our AI computes a continuous Mental Health Similarity Score, benchmarked against clinically validated profiles of depression and anxiety.

๐Ÿ“Š
04

Clinician Dashboard

You see real-time trends, alerts, and objective reports in the Behavidence Care platform โ€” without waiting for the next appointment.

The Platform

Everything You Need, In One Place

Behavidence Care is your clinical command center: patient dashboards, validated questionnaires, and automated RTM billing reports, all in one workflow.

๐Ÿ“Š Mental Health Dashboard

Daily Mood Trajectories, Automatically

Track each patient's MHSS score daily across Depression, Anxiety, ADHD, and Stress, with threshold alerts and automated questionnaire triggers built in.

  • Month-over-month behavioral trend visualization
  • Set custom alert thresholds per patient
  • Auto-trigger PHQ-9 when MHSS exceeds threshold
Mental Health Dashboard
Connect Clients
๐Ÿ”— Patient Onboarding

Onboard Patients in Under 60 Seconds

Generate an encrypted invite code and share it directly with your patient via email or QR code. Patients are connected to your clinic in minutes, no technical setup needed.

  • Encrypted patient codes for HIPAA compliance
  • Label patients by clinician or care team
  • Ready-to-send email template included
๐Ÿ“‹ Validated Questionnaires

Distribute Standardized Assessments Instantly

Send PHQ-9, GAD-7, MDQ, PCL-5, BAM, and more to individual patients or entire cohorts, with automated scoring and billable results.

  • 15+ validated instruments available out of the box
  • Automatic scoring with severity classification
  • Billable under CPT 96127 (behavioral assessment)
Questionnaires
The Science

Clinically Validated.
Not Just Another App.

Our Mental Health Similarity Score (MHSS) is built on peer-reviewed research and validated against clinically diagnosed populations โ€” not self-selected wellness users.

87%
Depression Detection Accuracy
76%
Anxiety Detection Accuracy
558+
Study Participants
4
Peer-Reviewed Studies
Feature
Behavidence
PHQ-9
Others
Data Collection
Passive & multimodal
Subjective (self-report)
Active / prompted
Reporting Frequency
Continuous (real-time)
Every 6 to 8 weeks
When prompted / periodic
Early Detection
48h lead time
Reactive (post-relapse)
Poor & reactive
Patient Burden
Zero (runs in background)
High (manual entry)
Medium (active interaction)
Peer-Reviewed
โœ“ 4 published studies
โœ“
โœ—
Billing & Reimbursement

Reimbursable Through Existing CPT Codes

Behavidence's passive monitoring platform is billable under Remote Therapeutic Monitoring (RTM) codes, no new billing infrastructure required.

CPT 98975
RTM Setup

Initial patient education and onboarding to the remote therapeutic monitoring platform.

CPT 98980
RTM Treatment Management

First 20 minutes of clinician time spent reviewing RTM behavioral health data monthly.

CPT 98981
RTM Add-On

Each additional 20-minute increment of RTM treatment management services.

CPT 96172
Health Behavior Intervention

Group health behavior assessment and intervention per 30 minutes for mental health monitoring.

Note: RTM codes (98975, 98980, 98981) require a minimum of 16 days of monitoring data per 30-day billing period. Behavidence's passive, continuous data collection satisfies this threshold automatically, with no patient action required.

One Click to a Billable RTM Report

Behavidence automatically tracks monitoring days, clinician review time, and suggested CPT codes, then generates a ready-to-submit PDF report in seconds.

RTM Report Generator
RTM PDF Report

Ready to Detect Relapse
Before It Happens?

Join clinicians already using Behavidence to deliver better outcomes for Esketamine, TMS, and SSRI patients.

We use cookies to enhance your browsing experience and analyze site traffic. By clicking "Accept", you consent to our use of cookies in accordance with our Privacy Policy and Terms of Service.